3-42590932-G-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001370300.1(SS18L2):āc.35G>Cā(p.Gly12Ala) variant causes a missense change. The variant allele was found at a frequency of 0.000013 in 1,305,762 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: not found (cov: 31)
Exomes š: 0.000013 ( 0 hom. )
Consequence
SS18L2
NM_001370300.1 missense
NM_001370300.1 missense
Scores
3
9
6
Clinical Significance
Conservation
PhyloP100: 5.58
Genes affected
SS18L2 (HGNC:15593): (SS18 like 2) Synovial sarcomas occur most frequently in the extremities around large joints. More than 90% of cases have a recurrent and specific chromosomal translocation, t(X;18)(p11.2;q11.2), in which the 5-prime end of the SS18 gene (MIM 600192) is fused in-frame to the 3-prime end of the SSX1 (MIM 312820), SSX2 (MIM 300192), or SSX4 (MIM 300326) gene. The SS18L2 gene is homologous to SS18.[supplied by OMIM, Jul 2002]
SEC22C (HGNC:16828): (SEC22 homolog C, vesicle trafficking protein) This gene encodes a member of the SEC22 family of vesicle trafficking proteins. The encoded protein is localized to the endoplasmic reticulum and may play a role in the early stages of ER-Golgi protein trafficking. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jan 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SS18L2 | NM_001370300.1 | c.35G>C | p.Gly12Ala | missense_variant | 1/3 | ENST00000011691.6 | NP_001357229.1 | |
SS18L2 | NM_016305.4 | c.35G>C | p.Gly12Ala | missense_variant | 2/4 | NP_057389.1 | ||
SEC22C | NM_001201572.2 | c.-28+10028C>G | intron_variant | NP_001188501.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SS18L2 | ENST00000011691.6 | c.35G>C | p.Gly12Ala | missense_variant | 1/3 | 1 | NM_001370300.1 | ENSP00000011691.4 | ||
SS18L2 | ENST00000447630.5 | c.35G>C | p.Gly12Ala | missense_variant | 2/4 | 2 | ENSP00000401115.1 | |||
SEC22C | ENST00000417572.5 | c.-28+10028C>G | intron_variant | 3 | ENSP00000407564.1 | |||||
SEC22C | ENST00000450981.5 | c.-179-3370C>G | intron_variant | 3 | ENSP00000397170.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 genomes
Cov.:
31
GnomAD3 exomes AF: 0.00000798 AC: 2AN: 250608Hom.: 0 AF XY: 0.00000738 AC XY: 1AN XY: 135558
GnomAD3 exomes
AF:
AC:
2
AN:
250608
Hom.:
AF XY:
AC XY:
1
AN XY:
135558
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000130 AC: 17AN: 1305762Hom.: 0 Cov.: 34 AF XY: 0.0000123 AC XY: 8AN XY: 648380
GnomAD4 exome
AF:
AC:
17
AN:
1305762
Hom.:
Cov.:
34
AF XY:
AC XY:
8
AN XY:
648380
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 31
GnomAD4 genome
Cov.:
31
Alfa
AF:
Hom.:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 17, 2024 | The c.35G>C (p.G12A) alteration is located in exon 1 (coding exon 1) of the SS18L2 gene. This alteration results from a G to C substitution at nucleotide position 35, causing the glycine (G) at amino acid position 12 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
.;T
M_CAP
Uncertain
D
MetaRNN
Uncertain
D;D
MetaSVM
Uncertain
T
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D
REVEL
Uncertain
Sift
Benign
D;D
Sift4G
Benign
T;T
Polyphen
D;D
Vest4
MutPred
Loss of loop (P = 0.0603);Loss of loop (P = 0.0603);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at